Showing results (271-280 of 296) with videos related to

Sort By:
Pageof 30
Chinese Medicine|February 24, 2010
Quality assurance for Chinese herbal formulae: standardization of IBS-20, a 20-herb preparationSiu-Po Ip, Ming Zhao, Yanfang Xian, et al.
Journal of Neurologic Physical Therapy : JNPT|March 7, 2017
Factors Associated With Ambulatory Activity in De Novo Parkinson DiseaseCory Christiansen, Charity Moore, Margaret Schenkman, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|January 11, 2012
Schisandra chinensis reverses visceral hypersensitivity in a neonatal-maternal separated rat modelJia-Ming Yang, Yan-Fang Xian, Paul S P Ip, et al.
Therapeutic Advances in Neurological Disorders|April 24, 2026
Efficacy and safety of apomorphine in the treatment of Parkinson's disease: a systematic review and meta-analysis of randomized controlled trialsMoaz Elsayed Abouelmagd, Abdallah Abbas, Obai Yousef, et al.
Breast Cancer Research and Treatment|November 18, 2020
A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopeciaMario E Lacouture, Hedy Dion, Shobha Ravipaty, et al.
Patient Preference and Adherence|January 30, 2015
Using the framework of corporate culture in "mergers" to support the development of a cultural basis for integrative medicine - guidance for building an integrative medicine department or serviceClaudia M Witt, Marion Pérard, Brian Berman, et al.
Journal of Drugs in Dermatology : JDD|February 6, 2023
The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Patients With Atopic Dermatitis: Randomized, Double-Blind, Phase 2 Proof of Concept StudyMelinda Gooderham, Leon Kircik, Matthew Zirwas, et al.
Dermatologic Clinics|September 10, 2017
Integrating Skin Cancer-Related Technologies into Clinical PracticeRichard R Winkelmann, Aaron S Farberg, Alex M Glazer, et al.
JAMA Dermatology|May 7, 2025
Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body: The ARRECTOR Phase 3 Randomized Clinical TrialMelinda J Gooderham, Javier Alonso-Llamazares, Jerry Bagel, et al.
CNS Neuroscience & Therapeutics|August 4, 2024
Determining the role of statins in Parkinson's disease risk reduction and disease modification: A comprehensive meta-analysis of 4 million participants' dataAbdelrahman Mady, Yehia Nabil, Asma Daoud, et al.
Pageof 30